** U.S.-listed shares of China-based healthcare services co
ZCMD.O up 7% at $2 premarket; set to open at near two-month
high if gains hold
** Co launches new line of business focusing on tumor and
rare disease patient management urn:newsml:reuters.com:*:nPn2gBdgSa
** Launch of patient management service focusing on
professional field of tumor and rare disease to be operated
through its unit
** Up to Thursday's close, stock had gained nearly 10% so
far this year
(Reporting by Shashank Nayar in Bengaluru)
((Shashank.Nayar@thomsonreuters.com; within U.S. +1 646 223
8780; outside U.S. +91 80 6182 2256;))